6-KETO-PROSTAGLANDIN-E1 IS NOT EQUIPOTENT TO PROSTACYCLIN (PGI2) AS AN ANTI-AGGREGATORY AGENT

被引：38

作者：

MILLER, OV

AIKEN, JW

SHEBUSKI, RJ

GORMAN, RR

机构：

来源：

PROSTAGLANDINS | 1980年 / 20卷 / 02期

关键词：

D O I：

10.1016/S0090-6980(80)80056-6

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：391 / 400

页数：10

共 50 条

[1] HEMODYNAMIC AND ANTI-AGGREGATORY EFFECTS OF PROSTACYCLIN-(PGI2) IN THE HEALTHY MAN
CHIERCHIA, S
CIABATTONI, G
CINOTTI, G
MASERI, A
PATRONO, C
PUGLIESE, F
DISTANTE, A
SIMONETTI, I
BERNINI, W
CIRCULATION, 1979, 60 (04) : 83 - 83
[2] 6-KETO-PROSTAGLANDIN-E1 AS AN ANTIAGGREGATORY, EFFECTIVE PROSTACYCLIN METABOLITE - BINDING TO PGI2 RECEPTORS AND ACTIVATION OF ADENYLATE-CYCLASE IN PLATELETS
JASCHONEK, K
WEISENBERGER, H
OSTENDORF, P
BLUT, 1984, 49 (03): : 231 - 231
[3] SPECIFICITY BETWEEN THE ANTI-AGGREGATORY ACTIONS OF PROSTACYCLIN, PROSTAGLANDIN-E1 AND D2 ON PLATELETS
WHITTLE, BJR
HAMID, S
LIDBURY, P
ROSAM, AC
ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1985, 192 : 109 - 125
[4] Comparison of anti-aggregatory effects of PGI2, PGI3 and iloprost on human and rabbit platelets
Kobzar, G
Mardla, V
Järving, I
Samel, N
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2001, 11 (05) : 279 - 284
[5] ANTI-AGGREGATORY ACTIVITY OF PGI2 IN WHOLE-BLOOD MEASURED BY PLATELET COUNTER
SPLAWINSKI, J
GWOZDZ, B
ZIEMBICKI, W
ZIAJOR, M
SPLAWINSKA, B
THROMBOSIS RESEARCH, 1984, 34 (02) : 93 - 102
[6] PARADOXICAL ANTI-AGGREGATORY EFFECT OF ADENOSINE 5'-DIPHOSPHATE (ADP) IN DOGS CORRELATES WITH RELEASE OF A PROSTACYCLIN (PGI2)-LIKE SUBSTANCE
HEMKER, DP
SHEBUSKI, RJ
AIKEN, JW
FEDERATION PROCEEDINGS, 1979, 38 (03) : 751 - 751
[7] 6-KETO PGE1 - A POSSIBLE METABOLITE OF PROSTACYCLIN HAVING PLATELET ANTI-AGGREGATORY EFFECTS
QUILLEY, CP
MCGIFF, JC
LEE, WH
SUN, FF
WONG, PYK
HYPERTENSION, 1980, 2 (04) : 524 - 528
[8] RENAL PRODUCTION OF 6-KETO-PROSTAGLANDIN-E1
PIERONI, JP
DRAY, F
MCGIFF, JC
CLINICAL RESEARCH, 1985, 33 (02): : A496 - A496
[9] 6-KETO-PROSTAGLANDIN-E1 - ITS FORMATION BY PLATELETS FROM PROSTACYCLIN AND RESISTANCE TO PULMONARY DEGRADATION
BERRY, CN
HOULT, JRS
PHARMACOLOGY, 1983, 26 (06) : 324 - 330
[10] FIBRINOLYTIC-ACTIVITY OF 6-KETO-PROSTAGLANDIN-E1
KORBUT, R
BYRSKADANEK, A
GRYGLEWSKI, RJ
THROMBOSIS AND HAEMOSTASIS, 1983, 50 (04) : 893 - 893

← 1 2 3 4 5 →